danazol,momelotinib
sierra oncology
['momentum', 'momelotinib', 'sierra oncology', 'sierra']
at s 2022 congress dr. alessandro vannucchi will present subset analysis from the momentum trial evaluating safety &amp; efficacy for patients with low platelet counts, demonstrating the use of momelotinib in thrombocytopenic patients. #eha22 
Sierra Oncology is on a mission to deliver targeted therapies that treat rare forms of cancer. $SRRA #myelofibrosis #raredisease #bloodcancer